Clinical study in which patients are randomized to receive hydroxychloroquine vs. Cyclosporine - hydroxychloroquine to compare their efficacy in the treatment of covid-19 pneumonia
Study Type
Interventional
Study Aim
Treatment and Management
Study Design
Parallel/Crossover
Intervention Assignment
Randomised
Population (7)
Male and Female
Pneumonia associated with COVID-19
Adult
Aged (65+)
Intervention (2)
Cyclosporine
Hydroxychloroquine
Comparison (1)
Hydroxychloroquine
Outcome (6)
Death
Time to clinical improvement
Adverse Event
Inflammation
SARS-CoV-2 RT-PCR
Mechanical ventilation
Clinical study in which patients are randomized to receive hydroxychloroquine vs. Cyclosporine - hydroxychloroquine to compare their efficacy in the treatment of covid-19 pneumonia